HENRY SCHEIN INC (HSIC)
US8064071025 - Common Stock
Taking everything into account, HSIC scores 5 out of 10 in our fundamental rating. HSIC was compared to 118 industry peers in the Health Care Providers & Services industry. HSIC has an average financial health and profitability rating. HSIC is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
HSIC had positive earnings in the past year.
In the past year HSIC had a positive cash flow from operations.
HSIC had positive earnings in each of the past 5 years.
In the past 5 years HSIC always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 3.93%, HSIC is doing good in the industry, outperforming 73.50% of the companies in the same industry.
The Return On Equity of HSIC (11.38%) is better than 79.49% of its industry peers.
The Return On Invested Capital of HSIC (6.66%) is better than 72.65% of its industry peers.
HSIC had an Average Return On Invested Capital over the past 3 years of 9.29%. This is in line with the industry average of 8.58%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.93% | ||
| ROE | 11.38% | ||
| ROIC | 6.66% |
ROA(3y)5.88%
ROA(5y)6.51%
ROE(3y)15.14%
ROE(5y)16.13%
ROIC(3y)9.29%
ROIC(5y)9.35%
1.3 Margins
With a decent Profit Margin value of 3.37%, HSIC is doing good in the industry, outperforming 75.21% of the companies in the same industry.
HSIC's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 5.71%, HSIC is doing good in the industry, outperforming 68.38% of the companies in the same industry.
HSIC's Operating Margin has declined in the last couple of years.
HSIC has a Gross Margin of 31.29%. This is comparable to the rest of the industry: HSIC outperforms 53.85% of its industry peers.
HSIC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.71% | ||
| PM (TTM) | 3.37% | ||
| GM | 31.29% |
OM growth 3Y1.22%
OM growth 5Y-4.64%
PM growth 3Y-5.48%
PM growth 5Y-9.94%
GM growth 3Y4.01%
GM growth 5Y0.25%
2. Health
2.1 Basic Checks
HSIC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, HSIC has less shares outstanding
Compared to 5 years ago, HSIC has less shares outstanding
HSIC has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.86 indicates that HSIC is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of HSIC (2.86) is better than 74.36% of its industry peers.
HSIC has a debt to FCF ratio of 7.51. This is a slightly negative value and a sign of low solvency as HSIC would need 7.51 years to pay back of all of its debts.
HSIC has a Debt to FCF ratio of 7.51. This is in the better half of the industry: HSIC outperforms 64.96% of its industry peers.
A Debt/Equity ratio of 0.60 indicates that HSIC is somewhat dependend on debt financing.
HSIC has a Debt to Equity ratio of 0.60. This is comparable to the rest of the industry: HSIC outperforms 54.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 7.51 | ||
| Altman-Z | 2.86 |
ROIC/WACC0.8
WACC8.3%
2.3 Liquidity
A Current Ratio of 1.67 indicates that HSIC should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.67, HSIC is doing good in the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 1.00 indicates that HSIC may have some problems paying its short term obligations.
HSIC's Quick ratio of 1.00 is on the low side compared to the rest of the industry. HSIC is outperformed by 65.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
HSIC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.46%.
The Earnings Per Share has been growing slightly by 1.68% on average over the past years.
Looking at the last year, HSIC shows a decrease in Revenue. The Revenue has decreased by -2.44% in the last year.
HSIC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.55% yearly.
EPS 1Y (TTM)-5.46%
EPS 3Y14.86%
EPS 5Y1.68%
EPS growth Q2Q-45.45%
Revenue 1Y (TTM)-2.44%
Revenue growth 3Y6.84%
Revenue growth 5Y5.55%
Revenue growth Q2Q-10.5%
3.2 Future
HSIC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.93% yearly.
HSIC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.71% yearly.
EPS Next Y15.06%
EPS Next 2Y13.3%
EPS Next 3Y12.19%
EPS Next 5Y10.93%
Revenue Next Year8.34%
Revenue Next 2Y6.7%
Revenue Next 3Y6.12%
Revenue Next 5Y6.71%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 15.06, HSIC is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of HSIC indicates a rather cheap valuation: HSIC is cheaper than 84.62% of the companies listed in the same industry.
HSIC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.28.
A Price/Forward Earnings ratio of 13.09 indicates a correct valuation of HSIC.
Based on the Price/Forward Earnings ratio, HSIC is valued cheaper than 83.76% of the companies in the same industry.
HSIC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.88, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.06 | ||
| Fwd PE | 13.09 |
4.2 Price Multiples
HSIC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HSIC is cheaper than 74.36% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, HSIC is valued a bit cheaper than the industry average as 64.96% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.82 | ||
| EV/EBITDA | 11.16 |
4.3 Compensation for Growth
HSIC's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
HSIC has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HSIC's earnings are expected to grow with 12.19% in the coming years.
PEG (NY)1
PEG (5Y)8.96
EPS Next 2Y13.3%
EPS Next 3Y12.19%
5. Dividend
5.1 Amount
No dividends for HSIC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HENRY SCHEIN INC
NASDAQ:HSIC (5/3/2024, 7:00:01 PM)
After market: 67.78 0 (0%)67.78
-0.82 (-1.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.71B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.06 | ||
| Fwd PE | 13.09 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1
PEG (5Y)8.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.93% | ||
| ROE | 11.38% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 5.71% | ||
| PM (TTM) | 3.37% | ||
| GM | 31.29% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-5.46%
EPS 3Y14.86%
EPS 5Y
EPS growth Q2Q
EPS Next Y15.06%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.44%
Revenue growth 3Y6.84%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y